CTNNB1 and neoplasm: Nevertheless, response heterogeneity remains substantial and is partly explained by tumor-intrinsic programs such as WNT/β-catenin (CTNNB1) activation that associate with immune exclusion phenotypes and attenuated benefit from immune checkpoint blockade.